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Summary
Background Several single-exposure studies have documented possible effects of environmental factors on lung 
function, but none has relied on an exposome approach. We aimed to evaluate the association between a broad range 
of prenatal and postnatal lifestyle and environmental exposures and lung function in children.
Methods In this analysis, we used data from 1033 mother–child pairs from the European Human Early-Life Exposome 
(HELIX) cohort (consisting of six existing longitudinal birth cohorts in France, Greece, Lithuania, Norway, Spain, and 
the UK of children born between 2003 and 2009) for whom a valid spirometry test was recorded for the child. 
85 prenatal and 125 postnatal exposures relating to outdoor, indoor, chemical, and lifestyle factors were assessed, and 
lung function was measured by spirometry in children at age 6–12 years. Two agnostic linear regression methods, a 
deletion-substitution-addition (DSA) algorithm considering all exposures simultaneously, and an exposome-wide 
association study (ExWAS) considering exposures independently, were applied to test the association with forced 
expiratory volume in 1 s percent predicted values (FEV₁%). We tested for two-way interaction between exposures and 
corrected for confounding by co-exposures.
Findings In the 1033 children (median age 8·1 years, IQR 6·5–9·0), mean FEV₁% was 98·8% (SD 13·2). In the 
ExWAS, prenatal perfluorononanoate (p=0·034) and perfluorooctanoate (p=0·030) exposures were associated with 
lower FEV₁%, and inverse distance to nearest road during pregnancy (p=0·030) was associated with higher 
FEV₁%. Nine postnatal exposures were associated with lower FEV₁%: copper (p=0·041), ethyl-paraben (p=0·029), 
five phthalate metabolites (mono-2-ethyl 5-carboxypentyl phthalate [p=0·016], mono-2-ethyl-5-hydroxyhexyl 
phthalate [p=0·023], mono-2-ethyl-5-oxohexyl phthalate [p=0·0085], mono-4-methyl-7-oxooctyl phthalate [p=0·040], 
and the sum of di-ethylhexyl phthalate metabolites [p=0·014]), house crowding (p=0·015), and facility density 
around schools (p=0·027). However, no exposure passed the significance threshold when corrected for multiple 
testing in ExWAS, and none was selected with the DSA algorithm, including when testing for exposure interactions.
Interpretation Our systematic exposome approach identified several environmental exposures, mainly chemicals, that 
might be associated with lung function. Reducing exposure to these ubiquitous chemicals could help to prevent the 
development of chronic respiratory disease.
Funding European Community’s Seventh Framework Programme (HELIX project).
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 
license. 
Introduction
The developmental period of a human, in both prenatal 
and early postnatal life, is likely to be particularly 
susceptible to environmental hazards. Exposures during 
this period could permanently affect body structure, 
physiology, and metabolism, leading to long-term health 
effects.1 For instance, in-utero tobacco smoke exposure 
increases the risk of altered pulmonary function and 
asthma.2
Besides smoking, there is evidence of variable strengths 
that exposure to other environmental factors could affect 
lung health in childhood. For example, prenatal exposure 
to outdoor air pollution is associated with respiratory 
symptoms, asthma, and deficits of lung growth in 
newborn babies.3 Among chemical exposures, there is 
moderate evidence for respiratory effects of some 
persistent organochlorine compounds, such as poly-
chlorinated biphenyls (used in the 20th century as 
electric insulators), and dichlorodiphenyltrichloroethane 
and its metabolite dichlorodiphenyldichloroethylene, a 
pesticide, for which human exposure occurs pre- 
dominantly via diet, including breastfeeding.4,5 Emerging 
concerns for lung effects of other man-made substances, 
such as perfluoroalkyl substances (PFASs) used in 
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non-stick cookware, water-repellent clothing, stain-
resistant fabrics, and carpets, or phthalate metabolites 
and phenols (including bisphenol A and ethyl-paraben)6,7 
used in the manufacture of plastics, solvents, and 
personal-care products, require further exploration. Few 
studies have considered the effects of metals on the 
developing respiratory system in humans.8
Pulmonary development in childhood is a key 
determinant for long-term respiratory function (as 
shown by studies of lung function deficits that have been 
tracked from childhood into adulthood—ie, the so-called 
tracking effect)9,10 and has been linked to health outcomes 
beyond just respiratory health. Indeed, studies have 
shown that low peak lung function in early adulthood is 
associated with a higher prevalence of respiratory, 
cardiovascular, and metabolic abnormalities in later life, 
and premature death.11 Therefore, it is essential to 
identify the environmental hazards affecting lung growth 
in childhood.
In daily life, populations are simultaneously exposed to a 
wide range of environmental factors that could affect 
health.12 The exposome, a concept defined as encompassing 
all environmental exposures from conception onwards,13 
offers a new paradigm in environmental health research. 
By simultaneously considering a large set of exposures, the 
exposome approach can overcome the limitations of 
focusing on a single exposure or family of exposures in 
environmental studies done so far.14 Specifically, exposome 
studies limit the risk of selective reporting (ie, testing 
many exposures and only reporting the most significant 
associations), and allow explicit reporting of multiple 
testing and correction for possible confounding by co-
exposures.
The aim of this study, based on a hypothesis-free 
approach, was to evaluate the association between prenatal 
and postnatal environmental exposures and forced 
expiratory volume in 1 s (FEV₁) in childhood in the large 
European Human Early-Life Exposome (HELIX) cohort.15
Methods
Study design and population
This study was part of the HELIX project, which is 
based on six existing longitudinal population-based 
European birth cohorts (Born in Bradford [BiB; UK], 
Étude des Déterminants Pré et Postnatals du 
Développement et de la Santé de l’Enfant [EDEN; 
France], Infancia y Medio Ambiente [INMA; Spain], 
Kaunas Cohort [KANC; Lithuania], Norwegian Mother 
and Child Cohort Study [MoBa; Norway], and Mother-
Child Cohort in Crete [RHEA; Greece]). Children in the 
cohorts were born in 2007–08 for BiB and RHEA, 
2003–05 for EDEN, 2005–07 for INMA and MoBa, and 
2007–09 for KANC, and all cohorts are still ongoing. In 
this study, we analysed the subcohort of 1301 mother–
child pairs from singleton pregnancies characterised by 
the HELIX project for a wide range of environmental 
exposures, including urban, chemical, and lifestyle 
exposures (inclusion and selection criteria have been 
described previously),15 from which we included 
children who did a valid spirometry test between the 
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Research in context
Evidence before this study
There is a large body of epidemiological literature on the 
effects of early-life exposures on respiratory health in children, 
but few studies have investigated several families of exposure, 
or applied an exposome approach—ie, one encompassing 
all environmental exposures from conception onwards. 
We searched PubMed for journal articles published in English 
up to Dec 17, 2018, with the search terms ((“Exposure” and 
“Environment”) OR (“Exposome”)) and (“Lung function” and 
“Epidemiology” and “Children”). We identified 295 articles, 
of which only 11 investigated at least two families of exposures 
and included few environmental exposures, and none relied on 
both exposure biomarkers and fine-scale environmental 
models. Populations are simultaneously exposed to a wide 
range of environmental factors, some of which are suspected to 
affect lung health. Therefore, the exposome approach warrants 
further investigation in respiratory epidemiology, particularly 
during early life, for which evidence is scarce.
Added value of this study
For the first time, to our knowledge, we were able to investigate 
the effect of a broad range of environmental exposures on lung 
function in children, by integrating 17 exposure families from 
the outdoor, indoor, chemical, and lifestyle domains of the 
exposome, assessed during pregnancy (85 exposures) and in 
childhood (125 exposures). We assessed pregnancy and 
childhood exposomes in 1033 mother–child pairs, with lung 
function measured by spirometry when children were aged 
6–12 years. A lower forced expiratory volume in 1 s was 
associated with prenatal exposure to perfluoroalkyl substances, 
with postnatal exposure to ethyl-paraben and phthalate 
metabolites (used in the manufacture of plastics, solvents, and 
personal-care products), copper, facility density near school, 
and house crowding, although no exposure passed the 
correction for multiple testing.
Implications of all the available evidence
Our study strengthened the evidence for the contribution of 
chemical exposures (phenols, phthalate metabolites, and 
perfluoroalkyl substances) to the impairment of lung function 
development and highlights the need for larger prospective 
studies. Preventive measures aimed at lowering exposure to 
the identified ubiquitous chemicals, through stricter 
regulation and through informing the public by labelling 
these chemicals in consumer products, could help to prevent 
early-life lung function impairment, which in turn might 
have benefits for long-term health.
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ages of 6 and 12 years. The full HELIX protocol and 
database are described in detail elsewhere.16
Characterisation of the exposome during pregnancy 
and childhood
A broad spectrum of environmental exposures covering 
17 exposure families were assessed in each mother–child 
pair, totalling 85 prenatal and 125 postnatal exposure 
variables (table 1).20 Briefly, exposures to outdoor factors 
were assessed from spatial and remote sensing data 
through a geographical information system. Chemical 
exposures were measured in plasma, serum, whole 
blood, or urine samples. During childhood, questionnaire 
information was collected on socioeconomic capital of 
the family, based on the Family Affluence Scale (FAS)21 
and through summary variables for social participation, 
social contact, and house crowding. Information on 
other lifestyle factors, including active and passive 
smoking, diet, or physical activity, was collected through 
questionnaires. Exposure assessment methods (appendix 
pp 3–15), levels, and correlation patterns for all exposure 
variables are described elsewhere12,20 and exposure level 
of our study population is described in the appendix 
(pp 16–24).
Spirometry data
The children were examined once between the ages of 
6 and 12 years as part of the HELIX subcohort follow-up 
visit according to common protocols across the 
six cohorts. Lung function was measured by a spirometry 
test (EasyOne spirometer; NDD [New Diagnostic Design], 
Zurich, Switzerland), by trained research technicians 
using a standardised protocol. The child, sitting straight 
and equipped with a nose clip, was asked to perform at 
Description
Atmospheric pollutants NO2, PM2.5, PM10, PMabs
UV Ambient UV radiation levels
Surrounding natural space Average Normalized Difference Vegetation Index within buffers of 100 m; presence of a major green space (ie, grass, trees, 
vegetation) or blue space (ie, visible water) within a distance of 300 m
Meteorology Air temperature as measured by meteorological stations (mean, minimum, and maximum); humidity percentage as 
measured by meteorological stations; atmospheric pressure data from the ESCAPE project
Built environment Population density: inhabitants per km²; building density: built area in m² of buildings per km² within a 300 m buffer; 
street connectivity: number of road intersections per km² within a 300 m buffer; accessibility: metres of bus public 
transport lines and number of bus public transport stops per km² within a 300 m buffer; facilities: facility richness index* 
and facility density index* within a 300 m buffer; land use evenness index†; walkability index‡ within a 300 m buffer
Traffic Total traffic load of major roads within a 100 m buffer, total traffic load within a 100 m buffer, traffic density on nearest 
road, and inverse distance to nearest road
Road traffic noise Night-time road noise levels, 24 h road noise levels
Organochlorine compounds Blood concentrations of dichlorodiphenyldichloroethylene, dichlorodiphenyltrichloroethane, hexachlorobenzene, 
PCB-118, PCB-138, PCB-153, PCB-170, and PCB-180, with lipid adjustment
Brominated compounds Blood concentrations of PBDE-47 and PBDE-153, with lipid adjustment
Perfluorinated alkylated 
substances
Blood concentrations of perfluorooctanoate, perfluorononanoate, perfluoroundecanoate, perfluorohexane sulphonate, 
and perfluorooctane sulphonate
Metals and essential elements Whole blood concentrations of arsenic, cadmium, ceasium, cobalt, copper, lead, manganese, mercury, molybdenum, 
and thallium
Phthalate metabolites Urine concentrations of monoethyl phthalate, mono-iso-butyl phthalate, mono-n-butyl phthalate, 
mono benzyl phthalate, mono-2-ethylhexyl phthalate, mono-2-ethyl-5-hydroxyhexyl phthalate, 
mono-2-ethyl-5-oxohexyl phthalate, mono-2-ethyl 5-carboxypentyl phthalate, 
mono-4-methyl-7-hydroxyoctyl phthalate, mono-4-methyl-7-oxooctyl phthalate, with creatinine adjustment
Phenols Urine concentrations of methyl-paraben, ethyl-paraben, bisphenol A, propyl-paraben, N-butyl-paraben, oxybenzone, 
and triclosan, with creatinine adjustment
Organophosphate pesticide 
metabolites
Urine concentrations of dimethyl phosphate, dimethyl thiophosphate, dimethyl dithiophosphate, diethyl phosphate, 
diethyl thiophosphate, and diethyl dithiophosphate, with creatinine adjustment
Water disinfection by-products§ Total concentration of total trihalomethanes, chloroform, and total brominated trihalomethanes estimated in tap water 
from water company concentration and distribution data
Indoor air¶ Prediction models for indoor air concentrations of NO2, PM2·5, PMabs, benzene, and TEX (toluene, ethylbenzene, xylene) 
using panel study data from indoor air samplers
Lifestyle Diet, physical activity, sleep duration, pets in the home
Socioeconomic capital Frequency of contact with family and friends, social participation, family affluence score, house crowding
ESCAPE=European Study of Cohorts for Air Pollution Effects. HELIX=Human Early-Life Exposome. NO2=nitrogen dioxide. PBDE=polybrominated diphenyl ether. 
PCB=polychlorinated biphenyl. PM2·5=particulate matter of less than 2·5 μm in aerodynamical diameter. PM10=particular matter of less than 10 μm in aerodynamical diameter. 
PMabs=absorbance of PM2·5 filters. UV=ultraviolet. *Developed by HELIX; facilities included businesses, community services, educational institutions, entertainment, financial 
institutions, hospitals, parks and recreation, restaurants, shopping, transportation hubs, and travel destinations. †Defined on the basis of the mathematical concept 
developed by Shannon and Weaver,17 using the FRAGSTATS software program. ‡Adapted from the previous walkability indices18,19 for the purposes of the HELIX project. 
§Only estimated for the prenatal window of exposure. ¶Only estimated for the postnatal window of exposure.
Table 1: List of prenatal and postnatal exposures16 assessed in this study
See Online for appendix
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least six manoeuvres (if possible). Data from unacceptable 
manoeuvres as a result of errors, including hesitation or 
false starts, cough, variable efforts, glottis closure, early 
termination, and leaks, were not retained by the 
technicians. The protocol required that at least three 
acceptable manoeuvres were obtained, and that they were 
reproducible, defined as a difference of less than 200 mL 
between the two highest values for forced vital capacity 
(FVC) and FEV₁ taken from the acceptable manoeuvres.
We then applied the following validation criteria on the 
spirometer curves retained by the technicians. We 
defined a manoeuvre as acceptable if there was no 
hesitation or false start (defined as a ratio of backward 
extrapolated volume [BEV] to FVC of <5% or a BEV of 
<100 mL if FVC was <1000 mL) and if the forced 
expiratory time was in an acceptable range (>1·5 s and 
<10 s). The two highest values for FEV₁ taken from 
acceptable forced expiratory manoeuvres could not vary 
by more than 150 mL or by more than 5% from the 
second FEV₁. To address the efficiency of the FEV₁ data 
cleaning, the 243 examinations from the INMA cohort 
(185 of which were included in the HELIX study) were 
further investigated by trained investigators who looked 
at the shape of the curves; for 192 (79%) of the 
243 examinations, the same curve was selected, and for 
the remaining 51 (21%), the Pearson correlation between 
the FEV₁ of the two different curves was 0·96.
We used the reference equations estimated by the 
Global Lung Initiative22 for computing the FEV₁ percent 
predicted values (ie, values standardised by age, height, 
sex, and ethnicity of the patient) and FEV₁ Z scores. After 
excluding extreme values (ie, FEV₁ <60% or >140%, which 
were probably due to measurement error in our young 
population), we selected the greatest FEV₁ value at an 
individual level among all accepted curves, hereafter 
referred to as FEV₁%.
Statistical analysis
Exposures were transformed to approach normality. 
After imputing missing data for all exposures and 
adjustment factors, exposures were standardised by the 
IQR (appendix p 12).20 We did statistical analyses for the 
prenatal (85 exposure variables) and the postnatal 
(125 exposure variables) exposome separately, using 
two approaches: a deletion-substitution-addition (DSA) 
algorithm, considering all exposures simultaneously, 
and an exposome-wide association study (ExWAS), 
considering exposures independently.23
DSA is an iterative linear regression model search 
algorithm, allowing at each iteration the removal of a 
term, substitution of one term for another, or addition of 
a term to the model. The final model is selected by 
minimising the value of the root-mean-squared error of 
predictions using five-fold cross-validated data. To 
stabilise estimates, the DSA was fitted 100 times on the 
data, and exposures were retained if they were selected in 
at least 5% of the runs. We repeated the DSA estimation 
testing for two-way interactions.24
The ExWAS consisted of a covariate-by-covariate 
estimation of the exposure–outcome association by 
independent linear regression models. For each 
exposure variable, results from the 20 imputed datasets 
were aggregated using Rubin’s rules for multiple 
imputed data such that a unique p value was obtained.25 
To correct for multiple hypothesis testing, each p value 
was compared with a threshold, defined as 0·05 divided 
by the effective number of tests,26 which estimates the 
number of truly independent tests that are done 
given the correlation structure of p values (46·5 and 
70·8 effective numbers of tests for the prenatal and 
postnatal exposome, respectively). To account for 
potential co-exposure confounding, we further included 
in a multivariable linear regression (MLR) model all the 
Exposure family Transformation 
before IQR 
standardisation
IQR ExWAS* ExWAS-MLR adjusting for 
potential confounding by 
co-exposure*†
Estimate 
(95% CI)‡
p value Estimate 
(95% CI)‡
p value
PFNA (µg/L) Perfluoroalkyl and 
polyfluoroalkyl 
substances
Log₂ 0·83 –1·4 (–2·7 to –0·1) 0·034 –0·8 (–2·8 to 1·2) 0·42
PFOA (µg/L) Perfluoroalkyl and 
polyfluoroalkyl 
substances
Log₂ 0·77 –1·4 (–2·7 to –0·1) 0·030 –0·6 (–2·6 to 1·3) 0·52
Inverse distance to 
nearest road (m–1)
Traffic Loge 1·17 1·2 (0·1 to 2·2) 0·030 1·1 (0·1 to 2·2) 0·030
ExWAS=exposome-wide association study. FEV1%=forced expiratory volume in 1 s in percent predicted. HELIX=Human Early-Life Exposome. IQR=interquartile range of the 
(transformed to approach normality) exposure variable. MLR=multivariable linear regression. PFNA=perfluorononanoate. PFOA=perfluorooctanoate. *Results are presented 
only for exposures with an (uncorrected for multiple hypothesis testing) p value of <0·05 in ExWAS. †Results from a multivariate linear regression model including all nine 
exposures with a (uncorrected for multiple hypothesis testing) p value of <0·20 in ExWAS except those that were too highly correlated (absolute correlation coefficient 
>0·90)—ie, PFOA, PFNA, inverse distance to nearest road, facility richness and facility density indexes, particular matter of less than 10 μm in aerodynamical diameter, 
presence of a major green or blue space, and total brominated trihalomethanes estimated in tap water. ‡Coefficient estimates are given for a change in mean FEV₁% for 
an IQR change in the given exposure.
Table 3: Adjusted association between the prenatal exposome (85 exposures) and FEV1% in 1033 children from the HELIX cohort (ExWAS analysis)
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exposure variables associated with FEV₁% with a p value 
of less than 0·20.
In previous simulation studies,23,24 DSA had better model 
selection efficiency than several other regression-based 
methods in an exposome context similar to ours, mainly in 
terms of the false-positive rate (28%). However, the 
complementary ExWAS approach allowed an improved 
sensitivity (96% for ExWAS vs 73% for DSA), at the cost of a 
higher false-positive rate (86%).23
We adjusted all our models for a set of adjustment 
factors that were selected from the literature: the centre 
of recruitment (with a fixed effects model, which provides 
unbiased estimates [unlike a random effects model, 
which can lead to biased estimates], and which DSA can 
cope with), the child’s sex, age, and height and parental 
country of birth (to avoid any residual confounding effect 
despite the fact that we accounted for these factors a 
priori when computing the percent predicted values), 
breast feeding duration, season of conception, presence 
of older siblings, parental education level, maternal age, 
maternal pre-pregnancy body-mass index (BMI), 
postnatal passive smoking status, and prenatal maternal 
active and passive smoking status.
The cohort-specific estimates were computed in-
dependently for each exposure in an exposure–cohort 
interaction ExWAS, and used to compute the I² statistic,27 
measuring the between-cohort heterogeneity of the 
association between the exposure and FEV₁% (the lower 
the I² value, the most consistent the association).
We also did sensitivity ExWAS analyses to address the 
robustness of our results to the following factors: (1) 
the choice of adjustment factors (first, not adjusting for the 
child’s age, sex, and height, and second, further adjusting 
for birth mode, gestational age, and the child’s BMI, 
although these factors could act as mediators in the 
association between the exposure and FEV₁); (2) the 
outcome definition, by considering the FEV₁ Z score; and 
(3) specific sub populations (considering first, exposure-
specific complete data; second, children who did not report 
a [nose] cold at the time of the spirometry test; third, 
children who had never been diagnosed with asthma by 
doctors; and fourth, children who had been diagnosed 
with asthma at least once). We did not adjust for asthma in 
our main analysis because asthma could be an intermediate 
variable in the causal link between the prenatal exposome 
and lung function.
All analyses were done using R software (version 3.4). 
We used the software packages rexposome for drawing 
plots, mice for multiple imputation, and DSA for the 
DSA algorithm.
Role of the funding source
The funders of the study had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Of the 1301 children in the HELIX project, 1033 (79%) had 
a valid FEV₁% value (≥70% of each cohort). FEV₁% ranged 
from 60·9% to 139·2%, with a median value of 98·6% 
(IQR 89·6–107·4) and a mean value of 98·8% (SD 13·2). 
At the time of the spirometry test, the median age of the 
1033 children was 8·1 years (IQR 6·5–9·0). Variations 
were observed between cohorts for both median FEV₁%, 
from 91·4% (84·9–98·6) in EDEN to 113·9% (103·9–120·2) 
in KANC, and age (table 2; appendix p 42).
The median maternal age at pregnancy was 31·0 years 
(IQR 27·7–34·1) and the infants were breastfed for a 
median of 5·2 weeks (3·9–6·0). 544 (53%) of 1033 were 
boys and 476 (46%) had no older sibling. Most clinical and 
demographic characteristics were similar between the 
1033 included and 268 excluded (because FEV₁% was not 
valid) mother–child pairs, but differed between cohorts 
(table 2).
With regard to the prenatal exposome, the ExWAS 
identified two perfluoroalkyl compounds—perfluoro-
octanoate and perfluorononanoate—associated with lower 
FEV₁% (p<0·05), with a mean FEV₁% change for each 
doubling in exposure level of –1·7% (95% CI –3·2 to –0·1) 
for perfluorooctanoate and –1·8% (–3·5 to –0·2) for 
perfluorononanoate. Table 3 and figure 1 present the 
results for an IQR increase in transformed exposure, for 
better comparability across exposures. Unexpectedly, the 
inverse distance to the nearest road during pregnancy was 
associated with an increased FEV₁% (mean change for a 
unit increase in loge-transformed exposure level was 1·0, 
95% CI 0·1–1·9). None of the exposure–FEV₁% 
associations remained statistically significant when 
correcting for multiple testing (p value threshold of 
0·001). Coefficients were consistent across cohorts 
(appendix pp 25–30, 43–44), although for the inverse 
Figure 1: Volcano plot of the coefficient estimates for prenatal exposure variables versus p value (uncorrected 
for multiple hypothesis testing) in the ExWAS analysis of the exposure–FEV₁% association
Coefficient estimates are given in FEV₁% fold change for an IQR change in the given exposure, which was previously 
transformed to approach normality. The dashed horizontal line shows where p=0·05. ExWAS=exposome-wide 
association study. FEV₁%=forced expiratory volume in 1 s in percent predicted. PFNA=perfluorononanoate. 
PFOA=perfluorooctanoate. 
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distance to nearest road the association was driven by the 
RHEA cohort (the association p value increased to 0·79 
when excluding this cohort, whereas all other leave-one-
cohort-out analyses of exposures identified in the prenatal 
and postnatal ExWAS gave p values of <0·30; data not 
shown). When adjusting for potential confounding due to 
co-exposure (jointly including the nine exposure variables 
associated at p<0·20), results remained consistent, but the 
magnitude of the association with perfluorooctanoate and 
perfluo- rononanoate decreased (table 3), probably because 
of their correlation with one another (r=0·61). The DSA 
model did not select any exposure–FEV₁% association, 
whether we tested for interaction terms or not.
For the postnatal exposome, the ExWAS identified nine 
exposure variables that were associated with a decrease in 
FEV₁%: four di-ethylhexyl phthalate (DEHP) metabolite 
exposures (mono-2-ethyl-5-oxohexyl phthalate [MEOHP], 
mono-2-ethyl-5-hydroxyhexyl phthalate [MEHHP], mono-
2-ethyl 5-carboxypentyl phthalate [MECPP], and the sum 
of all DEHP metabolites; these four variables were 
strongly correlated, with all absolute r values of >0·9; 
mean FEV₁% change for a doubling in exposure level 
between –1·6 [95% CI –2·8 to –0·4] and –1·3 [–2·5 to 
–0·2]); one di-iso-nonylphthalate (DINP) metabolite 
(mono-4-methyl-7-oxooctyl phthalate [OXOMiNP], –0·6%, 
95% CI –1·3 to –0·0); ethyl-paraben (–0·6%, –1·1 to –0·1); 
copper (–6·1%, –12·0 to –0·2); house crowding (mean 
FEV₁% change for a unit exposure increase, –1·1, 
–1·9 to –0·2); and facility density around school (mean 
FEV₁% change for a unit increase in loge-transformed 
exposure level –0·9, –1·8 to –0·1). Table 4 and figure 2 
present results for an IQR increase in transformed 
exposure, for better comparability across exposures. None 
of the exposure–FEV₁% associations remained statistically 
significant when correcting for multiple testing (p value 
threshold of 0·0007). No strong between-cohort 
heterogeneity (I²>0·40) was observed, except for facility 
density (I²=0·76), for which both negative (BiB, EDEN) 
and positive (RHEA) cohort-specific associations were 
observed (appendix pp 31–40, 45–47). When adjusting for 
potential confounding due to co-exposure, coefficient 
estimates remained similar but p values increased, and 
only those associated to ethyl-paraben and house crowding 
Exposure family Transformation 
before IQR 
standardisation
IQR ExWAS* ExWAS-MLR adjusting for potential 
confounding by co-exposure*†
Estimate (95% CI)‡ p value Estimate (95% CI)‡ p value
Facility density around school (number per km²) Built environment Loge 1·32 –1·2 (–2·3 to –0·1) 0·027 –1·1 (–2·6 to 0·4) 0·16
Copper (µg/L) Metals and elements Log2 0·16 –1·0 (–1·9 to –0·0) 0·041 –0·9 (–1·8 to 0·1) 0·064
Ethyl-paraben (µg/g of creatinine) Phenols Log2 0·98 –0·5 (–1·0 to –0·1) 0·029 –0·6 (–1·2 to –0·1) 0·030
Sum of DEHP metabolites (µg/g of creatinine) Phthalate metabolites Log2 0·85 –1·3 (–2·3 to –0·3) 0·014 –1·3 (–3·0 to –0·5) 0·15
MECPP (µg/g of creatinine) Phthalate metabolites Log2 0·87 –1·3 (–2·3 to –0·2) 0·016 § ··
MEHHP (µg/g of creatinine) Phthalate metabolites Log2 0·87 –1·2 (–2·2 to –0·2) 0·023 § ··
MEOHP (µg/g of creatinine) Phthalate metabolites Log2 0·84 –1·3 (–2·3 to –0·3) 0·0085 § ··
OXOMiNP (µg/g of creatinine) Phthalate metabolites Log2 1·34 –0·9 (–1·7 to 0·0) 0·040 –0·4 (–1·6 to 0·8) 0·50
House crowding (number of people) Socioeconomic capital None 1·00 –1·1 (–1·9 to –0·2) 0·015 –0·9 (–1·7 to 0·0) 0·039
DEHP= diethylhexyl phthalate. ExWAS=exposome-wide association study. FEV₁%=forced expiratory volume in 1 s in percent predicted. HELIX=Human Early-Life Exposome. IQR=interquartile range of the 
(transformed to approach normality) exposure variable. MECPP=mono-2-ethyl 5-carboxypentyl phthalate. MEHHP=mono-2-ethyl-5-hydroxyhexyl phthalate. MEOHP=mono-2-ethyl-5-oxohexyl phthalate. 
MLR=multivariable linear regression. OXOMiNP=mono-4-methyl-7-oxooctyl phthalate. *Results are presented only for exposures with an (uncorrected for multiple hypothesis testing) p value of <0·05 in 
ExWAS. †Results from a multivariate linear regression model including all 22 exposures with a (uncorrected for multiple hypothesis testing) p value of <0·20 in ExWAS except those that were too highly 
correlated (absolute correlation coefficient >0·90)—ie, facility density, building density around school, bus public transport lines around school, benzene in indoor air, presence of pets other than cats or dogs at 
home, house crowding, traffic density on nearest road to home address, presence of blue space around home address, copper, thallium, ethyl-paraben, methyl-paraben, oxybenzone, monobenzyl phthalate, 
mono-2-ethylhexyl phthalate, mono-4-methyl-7-hydroxyoctyl phthalate, OXOMiNP, sum of DEHP metabolites, diethyl phosphate, dimethyl thiophosphate, polybrominated diphenyl ether 153, and 
perfluorononoate. ‡Coefficient estimates are given for a change in mean FEV₁% for an IQR change in the given exposure. §The exposure variable was removed from the multivariate analyses because it was 
correlated at r>0·9 in absolute value with another exposure.
Table 4: Adjusted association between the postnatal exposome and FEV₁% in 1033 children from the HELIX cohort (ExWAS analysis)
Figure 2: Volcano plot of the coefficient estimates for postnatal exposure variables versus p value (uncorrected 
for multiple hypothesis testing) in the ExWAS analysis of the exposure–FEV₁% association Coefficient estimates 
are given as the FEV1% fold change for an IQR change in the given exposure, which was previously transformed to 
approach normality. The dashed horizontal line shows where p=0·05. ExWAS=exposome-wide association study. 
MECPP=mono-2-ethyl 5-carboxypentyl phthalate. MEHHP=mono-2-ethyl-5-hydroxyhexyl phthalate. 
MEOHP=mono-2-ethyl-5-oxohexyl phthalate. OXOMINP=mono-4-methyl-7-oxooctyl phthalate. 
*Sum of di-ethylhexyl phthalate metabolites. †Facility density within a 300 m buffer around school. 
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had a p value of less than 0·05. The DSA model did not 
select any significant exposure–FEV₁% associations, 
whether we tested for interaction terms or not.
All ExWAS results for the prenatal and postnatal 
exposures (reported for an IQR increase in transformed 
exposure, for better comparability across exposures) are 
presented in the appendix (pp 25–40), including results 
of the exposure–FEV₁% association by cohort.
All exposures identified in ExWAS had less than 
5% imputed values (<15% at the cohort level; appendix 
p 41). Each exposure displayed no absolute correlation 
above an r value of 0·7 with an exposure variable from 
another exposure family.
ExWAS results were robust to the choice of adjustment 
factors (appendix pp 48–49), to the outcome definition 
(when using FEV₁ Z scores; appendix pp 50–51) and to 
specific subpopulation (including to exposure-specific 
complete data; appendix pp 52–53). In the analysis of 
children with asthma, coefficients of the exposures 
remained consistent, but the 95% CIs increased given 
the lower sample size, and a stronger association between 
FEV₁% and perfluorooctanoate was observed.
Discussion
To our knowledge, this is the first study to address the 
effect of the exposome on lung function in children by 
considering a broad range of prenatal and postnatal 
environmental factors. Our results suggest that prenatal 
exposure to PFASs (perfluorononanoate and perfluoro-
octanoate) and postnatal exposure to copper, ethyl-
paraben, DEHP and DINP metabolites, and house 
crowding are associated with a lower FEV₁ in childhood.
Regarding the chemical exposures, we observed 
associations between lung function in childhood and 
prenatal perfluorooctanoate and perfluorononanoate 
exposures, which are ubiquitous synthetic fluorinated 
compounds typically used as stain repellents because of 
their surfactant properties and hydrophobicity. The 
majority of exposure to PFASs can be attributed to diet, in-
utero exposure through placental transfer, and 
breastfeeding. Our findings are in line with experimental 
studies reporting immunosuppressive effects of PFASs,28 
and animal models showing impaired lung development 
associated with exposure to PFASs—more specifically, 
induced airway inflammation and altered airway 
function29—possibly through oxidative stress mechan-
isms.7 To date, epidemiological evidence for a role of PFAS 
exposure in respiratory outcomes in humans is scarce; 
only two studies relying on objective measures of lung 
function have been published.7,30 One reported that 
postnatal concentrations of perfluorooctane sulphonate, 
perfluorooctanoate, perfluorohexane sulphonate, and 
perfluorononanoate were significantly negatively asso-
ciated with spirometry measures in 132 children with 
asthma, but not in children without asthma.7 Consistently, 
we noted a stronger association with prenatal perfluoro-
octanoate in children with asthma than in those without. 
Impinen and colleagues30 did not observe significant 
associations between prenatal exposure to PFASs and lung 
function at birth assessed from tidal breathing variables 
(ratio of time taken to achieve peak tidal expiratory flow to 
total expiratory time).30 Notably, Haug and colleagues12 
showed that perfluorooctane sulphonate and perfluoro-
octanoate exposures in mothers and children in the HELIX 
cohort often exceeded the HBM-I value (ie, the 
concentration of a substance in human biological material, 
above which individuals are considered at risk for adverse 
health effects according to the Human Biomonitoring 
Commission of the German Federal Environment 
Agency).12 From a public health perspective, our findings, 
combined with the observations from Haug and 
colleagues, advocate the reduction of exposure to PFASs.
The strongest exposure–FEV₁% associations identified 
in our study were with postnatal exposure to DEHP 
metabolites (MECPP, MEHHP, MEOHP, and sum of 
DEHP metabolites), and one DINP metabolite 
(OXOMiNP), which are mainly used as plasticisers and 
can be either ingested, inhaled, or absorbed through 
dermal contact. Several of these phthalates have been 
highlighted in the literature for their negative association 
with FEV₁ in adults31 and in children, and with other 
respiratory outcomes in children, including when exposed 
prenatally.6,32,33 DEHP metabolites are suspected to affect 
the respiratory system, especially in the paediatric age 
group, possibly by promoting immunological and 
inflammatory mediators.34 Our findings for DINP are of 
particular public health importance because the use of 
DINP is increasing in Europe as a substitute to DEHP, 
and it is now one of the most commonly used plasticisers.
Regarding phenols, we observed an inverse association 
with postnatal ethyl-paraben exposure, a compound used 
as  a preservative in cosmetics; this is in line with a 
previous observation of an association between ethyl-
paraben and FEV₁ at age 5 years in boys from the EDEN 
cohort, although for prenatal instead of postnatal 
exposure.6 Other epidemiological studies have suggested 
that bisphenol A could contribute to the development of 
respiratory disorders in children,35,36 but the timing of 
exposure and associated effects are conflicting. In 
the HELIX cohorts we did not identify an association 
between FEV₁ and prenatal or postnatal exposure to 
bisphenol A (0·4 [95% CI –0·7 to 1·6] and 0·4 [–0·4 to 1·2], 
respectively). This absence of association might partly be 
due to the exposure assessment from a single spot urine, 
which, for a compound with such a short half-life, leads 
to measurement error.35 This measurement error could 
considerably bias dose–response functions towards the 
null, especially because the compound has high within-
person variability.37 Regarding metals, we found that 
copper, which in the general population is mainly 
ingested through drinking water and diet, was associated 
with lower FEV₁; this observation is in line with previous 
studies in adults, and might relate to the pro-oxidant 
activity of copper.38
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Regarding socioeconomic factors, we found that a 
higher number of people living in the same house was 
associated with a lower FEV₁. The association between 
house crowding (median of four people per household in 
our population) and respiratory function is difficult to 
interpret, and epidemiological evidence is inconsistent.39 
On the one hand, in agreement with the hygiene 
hypothesis, house crowding is suspected to protect 
against allergic diseases.40 On the other hand, it might be 
a risk factor for asthma and lower lung function through 
increased contact with pathogens that cause lower 
respiratory infections.41
This study covered many more exposures related to the 
urban and outdoor environment than most previous 
epidemiological studies. Of these new indicators, only 
facility density around schools was associated with a lower 
FEV₁. Greater facility density or diversity is expected to 
create a more walkable environment, but could also be 
related to higher exposure to hazardous factors in the 
urban environment, such as air pollution, noise, and 
reduced green space,42 which could explain our association 
with a lower FEV₁. Regarding the atmospheric pollutants, 
meteorological factors, and green space indicators, which 
have rather well documented roles in child respiratory 
health,43–46 none was linked to lung function in children in 
the HELIX cohort, except for inverse distance to the 
nearest road during pregnancy; the lack of robustness of 
this association across the cohorts suggests that this 
association might be spurious, as can be expected from 
large exposome studies.23
The main strengths of this study include its reliance 
on prospectively collected data from six European 
countries, with detailed and comprehensive assessment 
of the internal and external exposome, both prenatally 
and in childhood. An objective measurement of lung 
function in childhood was used for this study, assessed 
using a standardised protocol. The association study was 
done in accordance with a statistical protocol that was 
based on simulation studies identifying the most 
efficient statistical approaches to be used in the 
exposome context.23,24 We relied on two regression 
methods that are complementary in terms of avoidance 
of false-positive and false-negative findings. The 
exposure–FEV₁ association estimates were reported for 
each exposure that was tested, avoiding problems of 
selective reporting.
Our study has several limitations. One relates to 
application of the exposome to real settings: with few 
financial and measurement tool resources, we had to 
make a choice in terms of the exposures that were 
investigated. This list does not include all exposures 
relevant for lung function (eg,  exposure to volatile 
organic compounds or pollens was not included), but it 
does cover the largest set of exposures studied thus far. 
Additionally, the data collected in HELIX did not allow 
us to analyse trimester-specific effects of the exposures 
assessed by biomarkers. Secondly, the statistical power 
is limited by the multiplicity of the exposures that were 
tested (and even more when testing for two-way 
interaction effects)24 and the rather small effect on lung 
function that is expected for these exposures; a larger 
population sample size could help to partly overcome 
this issue. Accounting for multiple comparisons in an 
exposome approach is not straightforward. However, 
compared with single-polluteant approaches, in which 
articles are independently published in a given cohort 
for several exposures without accounting for multiple 
exposure testing, the exposome approach represents a 
major step forward; it helps to avoid publication bias and 
allows better adjustment of exposure–health associations 
for potential co-exposure confounding, possibly at the 
cost of power because of multiple comparison 
corrections. Third, regarding environmental exposure 
assessment, measurement error bias is unavoidable and 
certainly of a different type and magnitude across the 
exposures. Therefore, in the context of the exposome 
approach, the comparison of the exposure–health 
association between exposures should be interpreted 
cautiously. Fourth, regarding the outcome assessment, 
although the spirometry tests were done by trained 
technicians following standardised protocols and current 
guidelines, forceful spirometry manoeuvres require 
strong patient cooperation, which is likely to be an issue 
for young children. Although we attempted to reduce 
this measurement error by refining acceptability and 
reproducibility criteria, the FEV₁ might have been 
underestimated for part of the study population; how 
this underestimation might have biased our estimate is 
difficult to say. Because young children are not always 
able to produce prolonged expirations to properly 
estimate lung volume, we did not analyse the ratio of 
FEV₁ to FVC, which might be more prone to 
measurement errors than FEV₁. We expect that the 
between-cohort variation in the FEV₁% values, for which 
the age difference across cohorts might partly be an 
explanation, would not have affected our results because 
our statistical analyses were all adjusted for centre of 
recruitment. Furthermore, each association observed at 
a p value of less than 0·05 was further investigated 
cohort by cohort to ensure that a similar pattern of 
association was observed across the cohorts. Finally, 
although a study of toxicological interactions between 
exposures would add to the holistic understanding of 
early environmental effects on lung function, many 
types of effects could be considered (eg, synergistic or 
antagonistic interactions), which we did not investigate 
in this study.
In conclusion, our study is, to our knowledge, the first 
to use a comprehensive exposome approach to report 
that specific prenatal and postnatal chemical exposures 
(phenols, phthalate metabolites, perfluoroalkyl sub-
stances) might be associated with the impairment of 
lung function development. These findings have 
important public health implications because they 
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suggest that preventive measures aimed at lowering 
exposure to the identified ubiquitous chemicals, through 
stricter regulation and informing the public by labelling 
these chemicals in consumer products, could help to 
prevent lung function impairment, which in turn should 
prevent the development of chronic respiratory disease 
in adulthood.
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